The FDA has announced that it has approved the first generic versions of Cymbalta (duloxetine delayed-release capsules) from Eli Lilly,...
The FDA has approved various strengths of generic formulations of Eli Lilly's antidepressant Cymbalta (duloxetine), following the recent loss of...
Daily Cymbalta( duloxetine) therapy from Eli Lilly, was effective and well-tolerated for the treatment of painful Chemotherapy-induced Peripheral Neuropathy (CIPN),...